SOCIETY FOR NEUROSCIENCE for SOCIETY FOR NEUROSCIENCE
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Animals ANI
Expressed positions of support of the ethical and responsible use of animals in biomedical research, including non-human primates and canine research, at Congressional office meetings at the US Senate and US House of Representatives. Included in community letters opposing language restricting and/or eliminating specific animal models used in biomedical research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN GRADY | — |
| MICHAEL HEINTZ | — |
Budget/Appropriations BUD
Advocacy efforts related to FY20 funding for: the National Science Foundation (NSF), the National Institutes of Health (NIH) and Department of Defense (DoD) and Veterans Affairs (VA) medical research programs. Additional advocacy efforts include stating support for continuing brain research as a top national priority as part of overall federal investment in biomedical research and efforts related to the BRAIN Initiative, as well as efforts towards raising the budget caps.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATHRYN GRADY | — |
| MICHAEL HEINTZ | — |
Science/Technology SCI
Included in community letter to Members of the U.S. House of Representatives in support of the "Securing American Science and Technology Act of 2019," which safeguards federally funded research and development from threats of foreign influence. Related efforts include general discussions around ensuring security from foreign influence of science while maintaining globally collaborative research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MICHAEL HEINTZ | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.